Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Ambrilia Biopharma Implements Cuts Two Senior Managers In Cost-Cutting Move

By Pharmaceutical Processing | July 29, 2009

Ambrilia Biopharma Inc. announced today that its Board of Directors has approved additional measures to effectively reduce costs which resulted in the lay-off of two senior managers, Dr. Philippe Calais, President & Chief Executive Officer, and Ms. Monique Letourneau, Executive Vice-President, Finance & Chief Financial Officer. Ambrilia also announced that Mr. Richard La Rue has been appointed Interim President & Chief Executive Officer and Mr. Brian Davies has been appointed Chief Financial Officer, effective immediately. Mr. La Rue and Mr. Davies have been employed by Ambrilia as Vice-President, Legal Affairs, Human Resources & Corporate Secretary and Director, Finance & Controller, respectively, since 2001. Commenting on the lay-offs, Mr. Frederic Porte, Chairman of the Board of Ambrilia, said “On behalf of Ambrilia’s Board, I wish to thank Dr. Calais and Ms. Letourneau for their contribution to the Company and wish them the best of success in their future endeavours”.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE